source
- Biotech reverse mergers rebound to highest level since 2021 as PIPEs flood market: reportReverse mergers have returned with a bang. More biotechs have taken the back door to the public markets so far in 2026 than in any full year since 2021, according to J.P. Morgan, with institutional…Fierce Biotech · 6h ago↗ source
- Rapport Therapeutics' epilepsy drug RAP-219 meets primary endpoint in bipolar mania Phase II trialRapport Therapeutics reported that its experimental pill RAP-219, originally developed for epilepsy, was tested in a mid‑stage study of adults with bipolar mania. The trial enrolled roughly 250 par…